Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
Driven by a surging pipeline, the MASH therapeutic landscape is radically transforming as more drugs reach clinical trials. While Madrigal's Rezdiffra marked a groundbreaking first approval, it also ...
Henry Lee Law (left) stands with his father, Amos Law. Amos was known for his successful moonshine business that brought him multiple stints in prison. He died Sunday at 83. Courtesy of Henry Lee Law ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback